Sagimet Biosciences (SGMT) Accumulated Expenses (2023 - 2024)
Sagimet Biosciences has reported Accumulated Expenses over the past 2 years, most recently at $814000.0 for Q3 2024.
- Quarterly results put Accumulated Expenses at $814000.0 for Q3 2024, down 63.64% from a year ago — trailing twelve months through Sep 2024 was $814000.0 (down 63.64% YoY), and the annual figure for FY2023 was $5.4 million, changed.
- Accumulated Expenses for Q3 2024 was $814000.0 at Sagimet Biosciences, down from $3.6 million in the prior quarter.
- Over the last five years, Accumulated Expenses for SGMT hit a ceiling of $5.4 million in Q4 2023 and a floor of $814000.0 in Q3 2024.